Ig development efforts using synthetic glycans to generate Igs to the TB specific MTX-1 motif, targeted by S4-20 [23] did not produce a successful product but highlight the potential for targeted Ig generation to epitopes. This evidence concerns the gene CUBN and tuberculosis.